"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 8 | 0 | 8 |
| 1996 | 7 | 1 | 8 |
| 1997 | 7 | 0 | 7 |
| 1998 | 9 | 0 | 9 |
| 1999 | 4 | 2 | 6 |
| 2000 | 13 | 2 | 15 |
| 2001 | 11 | 2 | 13 |
| 2002 | 15 | 1 | 16 |
| 2003 | 14 | 2 | 16 |
| 2004 | 12 | 1 | 13 |
| 2005 | 14 | 0 | 14 |
| 2006 | 20 | 3 | 23 |
| 2007 | 18 | 0 | 18 |
| 2008 | 26 | 0 | 26 |
| 2009 | 17 | 4 | 21 |
| 2010 | 16 | 3 | 19 |
| 2011 | 30 | 3 | 33 |
| 2012 | 21 | 2 | 23 |
| 2013 | 22 | 4 | 26 |
| 2014 | 22 | 6 | 28 |
| 2015 | 20 | 4 | 24 |
| 2016 | 20 | 3 | 23 |
| 2017 | 39 | 3 | 42 |
| 2018 | 28 | 1 | 29 |
| 2019 | 22 | 5 | 27 |
| 2020 | 42 | 4 | 46 |
| 2021 | 18 | 1 | 19 |
| 2022 | 31 | 1 | 32 |
| 2023 | 23 | 0 | 23 |
| 2024 | 32 | 1 | 33 |
| 2025 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis. Clin Cancer Res. 2025 Apr 14; 31(8):1400-1406.
-
Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation. Front Immunol. 2025; 16:1529707.
-
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Long-term follow-up, crossover, and rechallenge with pembrolizumab in the phase III KEYNOTE-716 study. Eur J Cancer. 2025 May 02; 220:115381.
-
Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76?K trial. Eur J Cancer. 2025 May 02; 220:115371.
-
Anticipation, perception, and recollection of acute pain from local anesthesia injection prior to Mohs surgery. Arch Dermatol Res. 2025 Feb 25; 317(1):490.
-
The potential impact of ACOG guideline changes on genital melanoma detection rates in females: a retrospective cross-sectional analysis and implications for clinical practice. Arch Dermatol Res. 2025 Feb 19; 317(1):438.
-
Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. Clin Cancer Res. 2025 Feb 03; 31(3):457-465.
-
Nicotinic Acetylcholine Receptor Expression in Merkel Cell Carcinoma Is Associated With Clinical and Histopathologic Parameters. J Cutan Pathol. 2025 Apr; 52(4):317-323.
-
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2025 Apr; 43(10):1219-1228.
-
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204. J Clin Oncol. 2025 Apr; 43(10):1210-1218.